[Corrigendum] FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β‑catenin nuclear accumulation

• Authors:
  • Ke Xu
  • Zhenhao Zhang
  • Hua Pei
  • Huamin Wang
  • Liang Li
  • Qianfeng Xia

• View Affiliations

  
  Affiliations: Department of Immunology, School of Tropical and Laboratory Medicine, Hainan Medical University, Haikou, Hainan 571101, P.R. China, Medical Technology Institute of Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China, Key Laboratory of Tropical Biomedicine, and Faculty of Tropical Medicine and Laboratory Medicine, Hainan Medical University, Haikou, Hainan 571101, P.R. China
• Published online on: November 9, 2020     https://doi.org/10.3892/or.2020.7842
• Pages: 403-403

• Copyright : © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

Oncol Rep 37: [Related article:] 2391-2397, 2017; DOI: 10.3892/or.2017.5459

Following the publication of the above article, an interested reader drew to the authors’ attention that an error was made in the assembly of the data panels shown in Fig. 4A. The ‘NC’ and ‘FoxO3a-KD’ panels (specifically, the upper left margins of the three ‘NC’ data panels and the lower right margins of the three ‘FoxO3a-KD’ panels) contained overlapping data. The authors were able to consult their original data, and realized that errors had occurred inadvertently during the figure compilation process.

Figure 4. Effect of FoxO3a depletion on N-cadherin distribution in U87-TR and U251-TR cells. (A and B) Immunofluorescence staining of N-cadherin in U87-TR and U251-TR cells. N-cadherin was partially localized at cell-cell contacts when FoxO3a was not depleted. By contrast, N-cadherin showed a diffuse localization pattern after FoxO3a depletion.

The revised version of Fig. 4A, featuring the corrected data panels for the ‘NC’ experiments, is shown opposite. The authors have confirmed that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum. Furthermore, they apologize to the readership of the Journal for any inconvenience caused.